| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |